Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 141 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Baseline Comparator Device Clear all

Conditions: Contraception
Interventions: SpeakOut, PartyWise; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 15 Years to 20 Years · Female only
Enrollment: 1,099 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Kidney Failure, Kidney Diseases
Interventions: Testim, 1% testosterone gel; Drug
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Palo Alto, California • San Jose, California

Conditions: Depression, Insulin Resistance, Metabolic Syndrome
Interventions: Metformin, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Resident Knowledge and Attitudes Regarding Cross-cultural Care, Interpersonal and Communication Skills in Patient-clinician Encounters, Patient-reported Satisfaction With Resident Physicians Involved in Their Care, Patients' Clinical Health Outcomes After Surgery
Interventions: PACTS curriculum, Standard Residency Curriculum; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2,901 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Boston, Massachusetts + 3 more

Conditions: Myocardial Infarction, Coronary Artery Bypass, Percutaneous Coronary Intervention, Heart Failure, Cardiac Valve Surgery
Interventions: RPE (usual care), GXT+THHR (intervention); Behavioral
Lead sponsor: Baystate Medical Center; Other
Eligibility: 60 Years to 99 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Springfield, Massachusetts • Detroit, Michigan

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder
Interventions: Counseling, Methylphenidate Hydrochloride, Phototherapy, Placebo Administration, Quality-of-Life Assessment, Sham Intervention, Therapeutic Melatonin; Other · Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chemotherapy-related Cognitive Impairment
Interventions: Low-Intensity Walking Intervention, Control Group Intervention; Behavioral
Lead sponsor: Ellis Medicine; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Schenectady, New York

Conditions: Contrast-induced Nephropathy
Interventions: Exposure to CBCIN risk score; Other
Lead sponsor: University of Chicago; Other
Eligibility: 21 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Keratoconus, Dry Eye, Allergy
Interventions: dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use, Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly; Drug
Lead sponsor: Illinois College of Optometry; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy Volunteer
Interventions: ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo, Moxifloxacin Hydrochloride; Drug
Lead sponsor: Angion Biomedica Corp; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Osteoporosis, Post-menopausal
Interventions: Romosozumab, Alendronate (Fosamax), Placebo Romosozumab, Placebo Alendronate; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer, Breast Neoplasms, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Cancer-related Cognitive Dysfunction
Interventions: Aerobic Exercise Training, Health Education (Active comparator); Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Breast Cancer
Interventions: Respiratory muscle strength training, Guided Imagery Exercises; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cerebrovascular Accident, Transient Ischemic Attack, ADHD
Interventions: atomoxetine, Stimulants, No intervention (general population); Drug · Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 72,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Heart Failure, Caregiver
Interventions: HEROIC program, Active Comparator Control 1; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 2
States / cities: Denver, Colorado • Baltimore, Maryland

Conditions: Thromboembolism
Interventions: IWPC adapted genotype-guided dosing algorithm for warfarin, Modified IWPC genetic-guided warfarin dosing algorithm, Standard of care treatment; Genetic · Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 2,415 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Amputation
Interventions: Prototype hand prosthesis, Baseline Comparator Device; Device
Lead sponsor: Össur Iceland ehf; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Opioid Use Disorder
Interventions: Disclosing Recovery: A Decision Aid and Toolkit; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Cognitive Function, Gaming Performance
Interventions: Placebo, Phosphatidylserine (100 mg), Phosphatidylserine (200 mg); Dietary Supplement
Lead sponsor: Lindenwood University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Heart Failure, Systolic
Interventions: Programming of CRT device settings; Device
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Gingivitis, DMFT Index, Dental Plaque Index, Oral Hygiene Education Methods, Oral Hygiene Reinforcement During Fixed Orthodontic Treatment, Motivational Interview, OHI
Interventions: Motivational Interviewing-Based Counseling, Standard Oral Health Education; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 14 Years to 19 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer, MET Alteration
Interventions: ANS014004 + PLB1004, ANS014004 + Osimertinib; Drug
Lead sponsor: Beijing Pearl Biotechnology Limited Liability Company; Industry
Eligibility: 18 Years and older
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Smoking, Nicotine Dependence
Interventions: Naltrexone, Bupropion; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Post Partum Depression, Perinatal Depression, Post Partum Anxiety, Perinatal Anxiety
Interventions: Baseline Assessment (18-26 weeks pregnant), Online Intervention and Phone Coaching Interventions, Follow Up Assessments: 34-36 weeks pregnant and 4-week postpartum, Follow Up Assessments: 8 weeks postpartum; Diagnostic Test · Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

The Share Health Study: Teen Social Connections and Health (Phase 2)

Testosterone Replacement Therapy in Advanced Chronic Kidney Disease

Endogenous Opioid Activity and Affective State in Insulin Resistant Women

The Provider Awareness and Cultural Dexterity Toolkit for Surgeons Trial

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

Breast Cancer, Reasoning, and Activity Intervention

Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

Hand Prosthesis Usability and Performance

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Dose-Response Effect of Phosphatidylserine on eSport Performance

Effects of CRT Optimization as Assessed by Cardiac MR

Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients

A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer

Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain

Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety